Interestingly, a recent study revealed that CD69+CD103-CD8+ TRM cell may perform a protective role in resolving liver fibrosis of nonalcoholic steatohepatitis (NASH) (39). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.